secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001601485-24-000083
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics shareholders elect directors, ratify auditor, approve share issuance
--------------------------------------------------------------------------------

- Three Class I directors elected: Robert Connelly (6,248,397 for), Katie Chudnovsky (6,233,264), Allen Nissenson (6,249,739).
- Ratification of Baker Tilly US, LLP as auditor for FY2024: 7,434,248 for, 1,188 against, 17,558 abstain.
- Approved issuance of shares upon exercise of warrants and convertible note per Nasdaq Rule 5635(b): 6,269,593 for, 81,508 against.
- Quorum of 7,452,994 shares voted (69.17% of voting power); all proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148524000083/0001601485-24-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148524000083/angn-20241121.htm
  HTML page:      https://secwatch.observer/filing/0001601485-24-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer